España
Italia
대한민국
日本
Français
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
Italia
대한민국
日本
Français
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Recent
Markets
Stock Trading Ideas
Transocean Stock Inches Higher After Q2 Report
Diamondback Energy Stock Dips After Q2 EPS Miss Estimates
Axon Enterprise Stock Climbs After Q2 Results: Here's Why
Diamondback Energy Stock Dips After Q2 EPS Miss Estimates
Axon Enterprise Stock Climbs After Q2 Results: Here's Why
Opendoor Q2 Preview: Newly Minted Meme Stock Tries To Win New Investors With Results, Turnaround Efforts
Trump Says Sweeney's Ad Is 'HOTTEST' — American Eagle Stock Goes Wild
Opendoor Q2 Preview: Newly Minted Meme Stock Tries To Win New Investors With Results, Turnaround Efforts
Trump Says Sweeney's Ad Is 'HOTTEST' — American Eagle Stock Goes Wild
Stock Of The Day: Breakout Time For D.R. Horton?
Can Super Micro's AI Demand Outpace Profit Margin Fears?
Read More...
Trading Ideas Recent News
MercadoLibre Stock Slips After Q2 Earnings Report: Details
Here's a look at the second-quarter earnings report from MercadoLibre.
Lucid Q2 Earnings Preview: Can Record Revenue, Strong Guidance Help Stock Momentum?
Lucid stock has risen in the past month with a partnership announced with Uber. Can Lucid provide more positive highlights for investors?
Rivian Q2 Earnings Preview: Will Investors Wait For R2 Launch, 2026 Catalysts?
Rivian remains low on catalysts ahead of the R2 launch in 2026. What could boost the stock after Q2 earnings?
Twist Bioscience Turns The Tide: Q3 Sales Jump, Beats Earnings
Twist Bioscience beat Q3 revenue estimates, improved gross margins, and narrowed its full-year outlook while forecasting EBITDA breakeven fiscal 2026.
Palantir Earnings Will Impact Market Sentiment; Rate Cut Hopes Fuel Buying
Our Trade On Joby Aviation
W.W. Grainger Analysts Cut Their Forecasts After Q2 Earnings
Stocks That Soared The Last Time Markets Were This Wobbly
These Analysts Raise Their Forecasts On nVent Electric After Strong Q2 Earnings
These Analysts Increase Their Forecasts On Regeneron Pharmaceuticals After Better-Than-Expected Earnings
These Analysts Lower Their Forecasts On Colgate-Palmolive After Q2 Results
Vertex Pharmaceuticals Likely To Report Q2 Profit; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
These Analysts Cut Their Forecasts On Newell Brands Following Q2 Results
Church & Dwight Analysts Slash Their Forecasts After Q2 Earnings